JP2024522237A5 - - Google Patents
Info
- Publication number
- JP2024522237A5 JP2024522237A5 JP2023577931A JP2023577931A JP2024522237A5 JP 2024522237 A5 JP2024522237 A5 JP 2024522237A5 JP 2023577931 A JP2023577931 A JP 2023577931A JP 2023577931 A JP2023577931 A JP 2023577931A JP 2024522237 A5 JP2024522237 A5 JP 2024522237A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence described
- sequence
- sequences
- sequence identity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163212409P | 2021-06-18 | 2021-06-18 | |
| US63/212,409 | 2021-06-18 | ||
| PCT/US2022/034188 WO2022266539A2 (en) | 2021-06-18 | 2022-06-20 | ANTIBODIES WHICH BIND HUMAN FIBRIN OR FIBRINOGEN γC DOMAIN AND METHODS OF USE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024522237A JP2024522237A (ja) | 2024-06-11 |
| JP2024522237A5 true JP2024522237A5 (https=) | 2025-06-27 |
Family
ID=84526539
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023577931A Pending JP2024522237A (ja) | 2021-06-18 | 2022-06-20 | ヒトフィブリンまたはフィブリノゲンγＣドメインに結合する抗体および使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240279357A1 (https=) |
| EP (1) | EP4355772A4 (https=) |
| JP (1) | JP2024522237A (https=) |
| AU (1) | AU2022293581A1 (https=) |
| CA (1) | CA3222934A1 (https=) |
| WO (1) | WO2022266539A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| WO2020160156A2 (en) | 2019-01-30 | 2020-08-06 | Immutics, Inc. | Anti-gal3 antibodies and uses thereof |
| EP4157338A4 (en) | 2020-05-26 | 2024-11-13 | TrueBinding, Inc. | METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005116235A2 (en) * | 2004-05-07 | 2005-12-08 | The Regents Of The University Of California | Endothelial cell apoptosis induced by fibrinogen gamma chain c-terminal fragment |
| HUE031571T2 (en) * | 2009-10-02 | 2017-07-28 | Univ California | Monoclonal antibodies |
| CA2896058A1 (en) * | 2012-12-24 | 2014-07-03 | Abbvie Inc. | Prolactin receptor binding proteins and uses thereof |
| SI3215527T1 (sl) * | 2014-11-05 | 2025-04-30 | Annexon, Inc. | Humanizirana protitelesa proti komplementnemu faktorju C1q in njihova uporaba |
| SI3445785T1 (sl) * | 2016-04-18 | 2022-11-30 | Faron Pharmaceuticals Oy, | Humanizirana protitelesa proti CLEVER-1 in njihova uporaba |
| MX2021001268A (es) * | 2018-08-01 | 2021-09-08 | Imcheck Therapeutics Sas | Anticuerpos anti-btn3a y su uso en el tratamiento del cáncer o trastornos infecciosos. |
-
2022
- 2022-06-20 WO PCT/US2022/034188 patent/WO2022266539A2/en not_active Ceased
- 2022-06-20 AU AU2022293581A patent/AU2022293581A1/en active Pending
- 2022-06-20 JP JP2023577931A patent/JP2024522237A/ja active Pending
- 2022-06-20 US US18/571,091 patent/US20240279357A1/en active Pending
- 2022-06-20 CA CA3222934A patent/CA3222934A1/en active Pending
- 2022-06-20 EP EP22825965.1A patent/EP4355772A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7586833B2 (ja) | 抗ＩｇＥ抗体 | |
| JP6526189B2 (ja) | 抗ｐｄ−ｌ１抗体並びにその治療及び診断のための使用 | |
| JP2024525188A5 (https=) | ||
| JP2024522237A5 (https=) | ||
| TWI482630B (zh) | 抗人類ｔｗｅａｋ抗體及其用途 | |
| JP2025522482A (ja) | インターロイキン１３に結合する抗体及び使用方法 | |
| JP2005532342A (ja) | Ｃｄ１６ａ結合タンパク質および免疫障害治療のための使用 | |
| JP6162319B2 (ja) | ヒト化抗ｎ２抗体 | |
| JP7490025B2 (ja) | Ｃｄ２００ｒアゴニスト抗体およびそれらの使用 | |
| EP3180358B1 (en) | Novel antibodies directed to fc gamma receptor iib and fc epsilon receptor | |
| WO2023242362A1 (en) | Fcrn/antigen-binding molecules and methods of use | |
| JP2012521771A (ja) | ヒトｔｗｅａｋに対する抗体とその使用 | |
| JP2023531230A5 (https=) | ||
| EP4619023A1 (en) | Anti-papp-a antibodies and methods of use thereof | |
| JP7697695B2 (ja) | ＩＬ－１β受容体シグナル伝達に干渉する剤 | |
| US20250154287A1 (en) | ANTI-MIGIS-alpha ANTIBODIES AND METHODS OF USE THEREOF | |
| HK40058421A (en) | Anti-ige antibodies | |
| EA048233B1 (ru) | Агонистические антитела к cd200r и их применение | |
| EA049400B1 (ru) | Антитела к ige | |
| HK40005909B (en) | Anti-pd-l1 antibodies and their use as therapeutics and diagnostics | |
| HK1186195B (en) | Antibodies against human tweak and uses thereof |